You can buy or sell Senseonics and other stocks, options, and ETFs commission-free!
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD. The listed name for SENS is Senseonics Holdings, Inc.
Timothy T. Goodnow
52 Week High
52 Week Low
Return On Capital Employed Overview: Senseonics Holdings, Inc. Common Stock
Senseonics Holdings, Inc. Common Stock (AMEX:SENS) reported Q3 sales of $767.00 thousand. Earnings fell to a loss of $12.47 million, resulting in a 0.46% decrea
— per share
Expected Mar 11, After Hours